Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies

Clinical trial NCT05783622 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05783622
Sponsor: Janux Therapeutics
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer Renal Cell Carcinoma Squamous Cell Carcinoma of the Head and Neck Colorectal Carcinoma Small Cell Lung Cancer Pancreatic Ductal Adenocarcinoma Triple-negative Breast Cancer

Start date: 2023-04-19
Primary completion: 2026-07-31
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.